Energetic Competition in the Complexation Affinity of Paracetamol with Water and Oxalic Acid
Abstract
The intermolecular interactions of active pharmaceutical ingredients (APIs) are the driving forces of API molecular activity in solid crystal structure and stability, in vivo receptor binding, and in environmental transport and persistence. In API manufacturing, complexation of the API with another molecule (cocrystal conformer) to create stable crystalline structures can be a useful tool, but the possibility of more energetically stable complexes forming instead of the target conformation can lead to undesired changes to the properties of the final product. Natural complexation of the API to cocrystal conformers in the environment can cause undesirable accumulation of the API. Using Density Functional Theory (DFT), the paracetamol and oxalic acid (PCA-OXA) cocrystal was studied to determine how hydrogen bonding dictates complex formation. Five different functionals were employed: B3LYP-D3, B3LYP-D3-BJ, M06-2X, M06-2X-D3, and B97-XD in combination with the aug-cc-pVDZ Dunning basis set. The hydrogen bonding sites of PCA-OXA were investigated to determine strength and overall contribution/competition of H-bonding formation during the initial stages of the nucleation process by relaxing the geometries and evaluating structural and energetic changes. Complexation and configuration energies were calculated for 1:1 PCA-OXA, PCA-Water, and OXA-Water complexes. Calculations were performed both in vacuum and in water environment (explicit and implicit solvation). Results showed…
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.